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ABSTRACT Objective. To identify specific health care areas whose optimization could improve population health in the 
Dutch Caribbean islands of Aruba and Curaçao.
 Methods. Comparative observational study using mortality and population data of the Dutch Caribbean 
islands and the Netherlands. Mortality trends were calculated, then analyzed with Joinpoint software, for the 
period 1988–2014. Life expectancies were computed using abridged life tables for the most recent available 
data of all territories (2005–2007). Life expectancy differences between the Dutch Caribbean and the Nether-
lands were decomposed into cause-specific contributions using Arriaga’s method.
 Results. During the period 1988–2014, levels of amenable mortality have been consistently higher in Aruba 
and Curaçao than in the Netherlands. For Aruba, the gap in amenable mortality with the Netherlands did not 
significantly change during the study period, while it widened for Curaçao. If mortality from amenable causes 
were reduced to similar levels as in the Netherlands, men and women in Aruba would have added, respec-
tively, 1.19 years and 0.72 years to their life expectancies during the period 2005–2007. In Curaçao, this would 
be 2.06 years and 2.33 years. The largest cause-specific contributions were found for circulatory diseases, 
breast cancer, perinatal causes, and nephritis/nephrosis (these last two causes solely in Curaçao).
 Conclusions. Improvements in health care services related to circulatory diseases, breast cancer, perinatal 
deaths, and nephritis/nephrosis in the Dutch Caribbean could substantially contribute to reducing the gap in 
life expectancy with the Netherlands. Based on our study, we recommend more in-depth studies to identify the 
specific interventions and resources needed to optimize the underlying health care areas.
Keywords Health evaluation; quality indicators, health care; Aruba; Curacao; Netherlands.
In the Kingdom of the Netherlands, life expectancies are 
lower in the Dutch Caribbean islands of Aruba and Curaçao 
than in the Netherlands (1). A recent study demonstrated that, 
in contrast to the Netherlands, Aruba and Curaçao did not 
experience substantial improvements in cardiovascular mor-
tality and have recorded increases in homicide and transport 
deaths during the period 1980–2014 (2). Although variations 
in mortality rates between populations are often the result of 
complex interactions between many factors—for example, 
socioeconomic conditions, health behaviors, and environ-
mental factors—there are indications that lack of access to 
quality health care services may also play a role.
Health care systems in the Kingdom of the Netherlands are 
built on the principle of solidarity and provide universal health 
care for its residents. General practitioners are the gatekeepers 
to health care services. In practice, this seems to work better in 
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the Netherlands than in Curaçao (3). While equal access to the 
system has, by and large, been achieved in the Netherlands (4), 
this was less the case in Curaçao: despite much higher morbid-
ity rates, people with a lower educational level in Curaçao were 
less likely to have consulted a specialist and to have been hos-
pitalized than those with a higher educational level (5). Part of 
the explanation was that waiting times for specialist care were 
longer for low-income patients (whose insurance payment 
model was based on a capitation fee) than for private patients 
(whose insurance payment model was based on fee-for-service) 
(6). Differences in payment models and waiting times have fun-
damentally improved with the introduction of the basic health 
care insurance in 2013 (7), but the results of a recent health 
survey showed that the consumption of specialist care did not 
reflect levels of morbidity (8). This may imply a continuation of 
undertreatment of those who need medical services the most, 
but can also suggest that overtreatment is common. Supporting 
this is the much higher utilization of general practitioner ser-
vices (9, 10) and prescription medications (11) compared to the 
Netherlands. No information on the accessibility and consump-
tion of health care services was available for Aruba.
Next to accessibility, the legal framework regulating health 
care quality lags behind in the Dutch Caribbean. Thirteen 
years after the introduction of the Individual Healthcare Pro-
fessions Act (the so-called BIG-wet) in the Netherlands, which 
regulates the qualification of health care professionals, a sim-
ilar law was proclaimed by the Curaçaoan parliament (2010). 
The underlying provisions have, however, not yet been imple-
mented. Aruba proclaimed a similar law, the AruBIG, in 2014. 
In the same year, Aruba also introduced legislation regulating 
the quality of health care providers, which is not foreseen in 
Curaçao for the near future.
Outcomes of health care services are not routinely monitored 
in the Dutch Caribbean, and the islands have limited research 
capacity. This demonstrates that policymakers’ needs for rel-
evant and timely information to identify issues, set priorities, 
support practices, and monitor progress to support health plan-
ning activities are not met. This study is an initial step and aims 
to identify health care areas whose optimization could improve 
population health in Aruba and Curaçao. The results will 
enable local governments to prioritize health care areas where 
improvements are possible and necessary.
Using the concept of amenable mortality, a widely adopted 
measurement of deaths that are considered unnecessary in the 
presence of timely and effective health care, this comparative 
observational study assesses the contribution of health care to the 
lower life expectancies in the Dutch Caribbean. Specifically, we 
aimed to 1) quantify differences in amenable and non-amenable 
mortality trends for Aruba, Curaçao, and the Netherlands 
during the period 1988–2014, and 2) estimate the contribution 
of amenable causes to life expectancy differences between the 
Dutch Caribbean islands and the Netherlands during the period 
2005–2007. Then, the results are discussed from a substantive 
perspective in light of health indicators and country reports.
METHODS
Data
Mortality data were obtained from the World Health Organi-
zation (WHO) mortality database or through a request to the Pan 
American Health Organization (PAHO) for Curaçao (12). Sub-
ject to data availability, data of the Netherlands for the period 
1988–2014, of Aruba for 1999–2014, of the Netherlands Antilles 
for 1988–1999, and of Curaçao for 2000–2007 were included. 
Data depict annual deaths by sex and age in each year, using 
the tenth revision of the International Classification of Diseases 
(ICD-10). Population data by sex and age were extracted from 
the United Nations World Population Prospects (WPP) 2017 (1). 
Data sources of health indicators from the Netherlands, Aruba, 
and the Netherlands Antilles/Curaçao are listed in the notes of 
Table 3.
Data adjustments
ICD-10 codes followed the classification of amenable deaths 
used by Nolte and McKee (13). Deaths were corrected for 
unclassified age and sex, for deaths attributed to ill-defined 
causes (R00–R99, non-external deaths only), and for under- 
registration (14), as determined by comparing the number 
of deaths with independent estimates from the WPP 2017 
(1). Based on the corrected numbers of deaths, we calculated 
age-standardized mortality rates per 100 000 population using 
direct standardization to the world standard population (15). 
Data of the Netherlands Antilles (which consisted of five island 
territories and was dissolved in 2010) and Curaçao (the most 
populous island territory of the former Netherlands Antilles 
accounted for 75% of the population) were depicted as a contin-
uous trend, since analyses showed a continuance of mortality 
trends between the Netherlands Antilles (NA) (1988–2000) and 
Curaçao (2001–2007). We refer to these territories as NA/
Curaçao.
Data analyses
For each territory, the annual percentage change in mortal-
ity trends during the period 1988–2014 were determined using 
Joinpoint software (version 4.2.0, National Cancer Institute, 
Bethesda, MD). A minimum number of 0 and a maximum num-
ber of 3 joinpoints were supplied and homoscedasticity was 
assumed. Life expectancies were computed using abridged life 
tables for the most recent available data for a three-year period, 
i.e., 2005–2007. To this end, population data and the corrected 
number of deaths from each territory were totaled to reduce 
sensitivity to small number fluctuations. Next, life expectancy 
differences between the Dutch Caribbean islands and the Neth-
erlands were decomposed into cause-specific contributions 
using Arriaga’s method. Calculations were performed using 
the Excel-template of Auger et al. (16). All datasets contain 
aggregate data unrelatable to identifiable persons.
RESULTS
Figure 1 demonstrates that the differences in amenable and 
non-amenable mortality between the Netherlands and the 
Dutch Caribbean islands were substantial. From 1988 through 
2014, both amenable and non-amenable mortality decreased 
steadily in the Netherlands, more rapidly for men than for 
women. In Aruba and NA/Curaçao, trends have taken a more 
fluctuating course due to their small populations, but levels of 
amenable and non-amenable mortality have been consistently 
higher than in the Netherlands.
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According to the results of the Joinpoint analyses (Table 1), 
amenable mortality has declined more rapidly than non- 
amenable mortality in all constituent countries, with the 
exception of women in NA/Curaçao. Despite the strong fluc-
tuations between 1999 and 2014, the overall trend in amenable 
mortality in Aruba has been downwards. A comparison of 
the slopes yielded non-significant results for both sexes; i.e., the 
annual percentage changes were statistically not significantly 
different between Aruba and the Netherlands. Consequently, 
the gap in amenable mortality between Aruba and the Netherlands 
did not significantly widen or narrow during the study period.
NA/Curaçao experienced a non-significant decline in amena-
ble mortality rates during the period 1988–2007 for both sexes. 
A comparison of the slope with that of the Netherlands yielded 
significant results for both sexes, indicating that the annual 
percentage changes are different between the Netherlands and 
NA/Curaçao. In contrast to the Netherlands, the NA/Curaçao 
population did not experience a decline of amenable mortality 
during the study period, so that the gap in amenable mortality 
with the Netherlands widened.
Table 2 shows how much separate amenable causes of death 
contributed to the difference in life expectancy between the 
Netherlands and the Dutch Caribbean islands during the latest 
time period for which data for all three constituent countries 
are available, i.e., 2005–2007. In Aruba, amenable mortality 
accounts for 19% (men) and 17% (women) of the total mortality 
gap with the Netherlands. For NA/Curaçao this is substan-
tially more, with 37% and 75%, respectively.
If mortality from amenable causes were reduced to similar 
levels as in the Netherlands, men and women in Aruba would 
add, respectively, 1.19 years and 0.72 years to their life expec-
tancies. In Curaçao, this would be 2.06 years and 2.33 years. 
Mortality improvements for amenable circulatory causes (which 
includes ischemic heart disease, cerebrovascular disease, and 
hypertensive disease) to the level of the Netherlands would 
add respectively 1.02 years and 0.56 years to the life expectancy 
of men and women in Aruba. In NA/Curaçao, this would be 
0.65 years and 0.55 years. Perinatal deaths are an important 
additional contributing cause of death in NA/Curaçao, and are 
responsible for 0.79 years (men) and 0.90 years (women) of the 
FIGURE 1. Trends in age-standardized mortality rates for amenable and non-amenable causes for Aruba, the Netherlands Antilles 
(NA)/Curaçao, and the Netherlands, ages 0–74 years, 1988–2014
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TABLE 1. Results of Joinpoint software analyses of trends for amenable and non-amenable mortality for 
Aruba, the Netherlands Antilles (NA)/Curaçao, and the Netherlands. Comparison of the Netherlands with 
Aruba is based on data from the period 1999–2014; comparison of the Netherlands with NA/Curaçao is 
based on data from the period 1988–2007.
Amenable mortality Non-amenable mortality
Trend APC Test for parallelism Trend APC Test for parallelism
Men
The Netherlands -4.72* 0.422 -2.88* 0.007
Aruba -3.99* -1.40*
The Netherlands -3.57* 0.000 -2.20* 0.000
NA/Curaçao -0.05   0.68*
Women
The Netherlands -3.64* 0.449 -1.49* 0.129
Aruba -2.79* -2.50*
The Netherlands -2.37* 0.002 -0.52* 0.415
NA/Curaçao -0.18   -0.74*
APC annual percentage change
Notes: * significant trend change, APC is significantly different from zero (two-side p < 0.05)
Source: Author’s own calculations.
TABLE 2. Results of Arriaga’s decomposition method analyses of life expectancy differences between the 
Dutch Caribbean islands of Aruba and Curaçao and the Netherlands, 2005–2007
Men Women
Aruba Curaçao Aruba Curaçao
Difference in life expectancy (years) with the Netherlands due to:
All causes of death 6.24 5.62 4.12 3.10
Non-amenable causes 5.05 3.57 3.41 0.77
Amenable causes 1.19 2.06 0.72 2.33
% of the difference due to amenable causes 19.1 36.6 17.4 75.1
Amenable causes
Infectious diseases 0.01 0.01 0.01 0.00
Treatable cancers, among which: 0.05 0.04 0.18 0.35
- Colon and rectum 0.03 0.08 -0.08 0.10
- Breast -- -- 0.22 0.21
- Cervix and uterus -- -- 0.01 0.01
Diabetes 0.00 0.03 0.05 0.08
Ischemic heart disease (50% of deaths) 0.33 0.22 0.12 0.15
Cerebrovascular disease 0.34 0.20 0.32 0.20
Respiratory diseases 0.03 0.07 -0.06 0.06
Digestive diseases 0.00 -0.01 0.01 0.01
Perinatal deaths 0.09 0.79 -0.10 0.90
Other amenable conditions, among which: 0.34 0.40 0.19 0.58
- Hypertensive disease 0.35 0.23 0.12 0.20
- Nephritis and nephrosis 0.03 0.12 0.02 0.21
Source: Author’s own calculations.
total mortality gap with the Netherlands. Nephritis/nephro-
sis is also important, especially for NA/Curaçao. In addition, 
reduction in breast cancer mortality to the level of the Neth-
erlands would add 0.22 years in Aruba and 0.21 years in NA/
Curaçao to female life expectancy.
DISCUSSION
The results show that deaths from amenable causes sub-
stantially contribute to the life expectancy differences between 
the Caribbean islands of Aruba and NA/Curaçao and the 
Netherlands. In Aruba, amenable deaths comprise 19% (men) 
and 17% (women) of the total life expectancy difference with 
the Netherlands. In NA/Curaçao, this is 37% and 75% respect-
ively. The larger relative contribution of amenable deaths in 
NA/Curaçao is mainly due to its relatively high mortality from 
perinatal causes and nephritis/nephrosis. As the contribu-
tion in years is comparable between men and women in NA/
Curaçao, the large sex difference is explained by the relatively 
large contribution of non-amenable mortality among males. 
Non-amenable mortality rates were also higher in the Dutch 
Caribbean islands than in the Netherlands, especially for men, 
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
N61
Verstraeten et al. • Amenable mortality and life expectancy differences Original research 
Rev Panam Salud Publica 44, 2020 | www.paho.org/journal | https://doi.org/10.26633/RPSP.2020.38 5
for whom the gap with the Netherlands has strongly diverged 
during the study period. A previous study showed that the 
divergence of non-amenable mortality was largely due to 
increased mortality from homicide and transport accidents (2).
All in all, amenable mortality plays a larger role in the life 
expectancy gap with the Netherlands for NA/Curaçao than 
for Aruba. Ischemic heart disease, cerebrovascular disease, 
hypertensive disease (hereafter circulatory diseases), and 
breast cancer are the underlying causes of death with the 
largest contribution to life expectancy differences with the 
Netherlands. In NA/Curaçao, perinatal deaths and nephritis/
nephrosis also play a role. Medical interventions that help to 
prevent deaths from these causes have been comprehensively 
described elsewhere and are briefly summarized here (17). 
Increased detection efforts for hypertension, improvements 
in the treatment of hypertension from the 1950s onwards, 
and the intensive management of stroke in coronary care 
units, have significantly reduced mortality from circulatory 
diseases. Breast cancer mortality declined after the introduc-
tion of population screening programs (mammography) and 
treatment with tamoxifen, even though the effectiveness of the 
first intervention remains a topic of dispute (18). Declines in 
deaths from perinatal causes have been the result of advances 
in the treatment for specific conditions, such as rhesus immu-
nization and surfactant, and the incremental introduction of a 
wide range of interventions, such as special baby care units, 
and local intensive and ventilator care. The key interventions 
in reducing deaths from nephritis/nephrosis were dialysis 
and renal transplantation, and graft survival for the latter 
treatment was further improved after the introduction of cic-
losporin in the 1980s.
Based on the available health indicators (Table 3) and infor-
mation from country reports, there are several indications 
that patients with these disorders, or their underlying risk 
factors, do not receive adequate curative and preventive care 
in the Dutch Caribbean. During a health examination survey 
in Curaçao, blood pressure control was 32% among respond-
ents that were previously diagnosed with hypertension (8). 
While data from the Netherlands were not directly compara-
ble because of different study methods, control of hypertension 
appears substantially higher among Dutch men (53%) and 
women (61%) in Amsterdam (19). Among diagnosed diabetics 
in Curaçao, 35% had a normal blood glucose level (8), whereas 
67% of diabetic men and 47% of diabetic women in Amsterdam 
had HbA1c levels on target, which suggests that blood glucose 
control is also less favorable in Curaçao (20). This demonstrates 
that the prevalence of uncontrolled hypertension and diabetes, 
and subsequently the proportion of people that are at risk for 
related complications such as nephritis/nephrosis, is relatively 
high in Curaçao. Information on hypertension or blood glucose 
control in Aruba was not available.
Moreover, in order to prevent complications, it is recom-
mended that patients with diabetes have regular eye and foot 
examinations (Dutch College of General Practitioners (NHG) 
guidelines). In 2017, 67% of diabetics in Curaçao had under-
gone a clinical eye examination in the past two years, and 29% 
had undergone a clinical foot-examination, a drop of 9% and 
7%, respectively, compared to 2013 (8). A severe complication 
of untreated diabetes is kidney disease. As another indication 
that the detection and/or treatment of diabetes is inadequate 
in Curaçao, the proportion of dialysis patients was four times 
higher than in the Netherlands (Table 3). Concerns about an 
TABLE 3. Overview of comparable health indicators for Aruba, the Netherlands Antilles (NA)/
Curaçao, and the Netherlands
Year The Netherlands Aruba NA/Curaçao
Cancer care
Participated in screening of:1 Ca. 2017
- Cervix cancer 56.9 - 48.9
- Breast cancer 77.3 - 43.3
- Colon cancer 72.7 - 25.4
Mortality-to-incidence ratio:2 2005–2010 (latest available)
- Cervix 0.28 0.32 0.33
- Breast 0.21 0.29 0.28
- Colon and rectum 0.40 0.39 0.47
Mother-and-child care
Maternal mortality (per 100 000 births)3 2003–2007 6.0 16.4 47.2
Immunization coverage <1 year (%)4 2016
- DTP3 and polio 3 93.5 (97.0) 85.0
- PCV3 93.6 (93.0) 74.0
- MMR 1 90.9 (97.0) 78.0
Noncommunicable diseases
Kidney dialysis patients, per 100 000 population5 2014 38.3 - 163.9
Source:
1.  https://www.volksgezondheidenzorg.info/onderwerp/bevolkingsonderzoek; Curaçao, Volksgezondheid Instituut Curaçao (2017) De Nationale Gezondheidsenquête.
2.  Morbidity data. The Netherlands (2019) https://www.cijfersoverkanker.nl; Aruba, Ministry of Public Health and Sports (2013) Health Monitor Aruba; Curaçao, Volksgezondheid 
Instituut Curaçao (2014) Gezondheidsdatabank. Mortality data. WHO mortality database, April 2018 update. Available from: https://www.who.int/healthinfo/mortality_data/en/
3.  World Health Organization. WHO mortality database, April 2018 update. Available from: https://www.who.int/healthinfo/mortality_data/en/
4.  The Netherlands, RIVM (2016) Vaccinatiegraad Rijksvaccinatieprogramma Nederland; Aruba and Curaçao, PAHO PLISA database (2019) https://www.paho.org/data/index.php/en/
indicators/visualization.html
5.  The Netherlands, Nefrodata (2019) https://ivisualz.nl/ivisualz/chartFlash/charts; Curaçao, Volksgezondheid Instituut Curaçao (2014) Gezondheidsdatabank.
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alarmingly high number of complications related to diabetes 
were confirmed in Aruba as well (21). Further investigation 
should ascertain whether the differences in nephritis/nephrosis 
mortality between Aruba and Curaçao are due to an increased 
effectiveness of chronic disease care in Aruba that prevents the 
severe complications from hypertension and diabetes, or are, 
for example, the result of different practices in the diagnosis 
and treatment of renal failure.
A national breast screening program was introduced in the 
Netherlands in 1989. In NA/Curaçao, a similar program was 
initiated by a private foundation in 2010, and only received 
financial support from the local government in 2017. A national 
breast screening program was introduced in Aruba in 2016. In 
2017, breast cancer screening rates in Curaçao were lower than 
in the Netherlands, which may partially explain the higher 
mortality-to-incidence ratios on the island (Table 3). Informa-
tion on breast cancer screening rates were not available for 
Aruba. No information on the effectiveness of breast cancer 
treatment in the Dutch Caribbean was available, as cancer sur-
vival rates are not published by local hospitals.
Curaçao also struggles with providing sufficient coverage in 
other areas of preventive care. For cervix and colorectal cancer, 
relatively low screening rates and high mortality-to-incidence 
ratios were recorded (Table 3), which suggests room for fur-
ther improvements in the diagnosis and/or treatment of these 
diseases. The association of general practitioners in Curaçao rec-
ommends an annual seasonal flu vaccination for every person 
at risk, but only 6% of the target population had received one 
during the 2016 season (8). Moreover, the procedures necessary 
to quickly detect and respond to infectious disease outbreaks 
are non-existent in Curaçao (22), and childhood immunization 
coverage is below 95% (Table 3). This is especially concerning in 
light of the resurgence of vector-borne and vaccine-preventable 
outbreaks in Venezuela, the neighboring country (23, 24). It is 
unclear whether the high coverage recorded in Aruba indeed 
reflects higher population immunization rates, as the reported 
estimates preceding the introduction of the child monitoring 
system from Curaçao also consistently depicted an overly opti-
mistic coverage of >95%.
Perinatal deaths stem from health care related causes such 
as the inappropriate management of complications during 
pregnancy and delivery. During the study period, perina-
tal mortality was consistently higher in NA/Curaçao than in 
Aruba and the Netherlands. Curaçao also recorded a mater-
nal mortality ratio that was three times higher than in Aruba 
(Table 3). This suggests that the effectiveness of mother-and-
child care is unsatisfactory in Curaçao. An important reason 
for Curaçao’s poorer outcomes could be the fragmented orga-
nization of perinatal care services, with midwives providing 
services in the maternity clinic, and gynecologists in private 
practices and the main hospital located several kilometers 
away. In Aruba, in contrast, midwives and gynecologists work 
closely together in the main hospital. Further investigation 
should determine whether the low perinatal mortality in Aruba 
reflects lower incidences of underlying risk factors, better care 
during the antenatal period and during delivery, and/or a reg-
istration artefact, for example, from the exclusion of stillbirths.
All in all, the information on health care in the Dutch 
Caribbean suggests that the excess amenable mortality from 
circulatory diseases, breast cancer, perinatal deaths, and nephri-
tis/nephrosis in the Dutch Caribbean, at least partly, reflects 
differences in the effectiveness of health care services between 
the Dutch Caribbean and the Netherlands. As we mentioned 
earlier, this study is an initial step to identify health care areas 
whose optimization could improve population health in the 
Dutch Caribbean islands of Aruba and Curaçao. This enables 
the local governments to prioritize health care areas where 
improvements are possible and necessary, but does not allow to 
specify which improvements in health care processes will most 
likely lead to improved population health outcomes. There-
fore, more in-depth studies investigating care delivery related 
to these amenable causes of death are necessary to identify the 
interventions and resources needed for health care strengthen-
ing in the Dutch Caribbean. One specific recommendation is to 
evaluate the access and quality of noncommunicable disease 
services delivered at primary and secondary health care facil-
ities, with the objective to scale up the prevention, detection, 
treatment, and follow-up of hypertension and diabetes. Simi-
larly, a quality-of-care audit can identify suboptimal processes 
in mother-and-child services: implementation of recommenda-
tions from quality-of-care audits have been shown to reduce 
perinatal deaths by up to 30% (25).
In further investigations, the small scale of the Dutch Carib-
bean islands should be taken into account. The volume of certain 
complex specialist interventions, for example, may be too low 
to guarantee quality of care, which increases the risks of mor-
tality from the underlying conditions. To illustrate, surgeons in 
the Netherlands commonly offer services in a specific area of 
specialization, while most surgeons in Aruba and Curaçao offer 
general services. Also, medical treatment abroad may be nec-
essary because not all medical specializations are available on 
the islands, which is likely to increase the waiting time to start 
treatment for certain procedures. Nevertheless, every health 
care system, big or small, needs to be optimized to provide the 
best care that the available resources can buy.
Our study has several limitations. First, the analyses are con-
strained by the limited availability of mortality statistics, by the 
uncertain accuracy and consistency of cause-of-death certifica-
tion and coding, and by the relatively small populations of the 
Dutch Caribbean. Preferably, mortality data would have been 
available for the complete study period in all territories of the 
Kingdom of the Netherlands, but this was not the case and is an 
important fact in itself, illustrating severe shortcomings in health 
monitoring systems. Data of Aruba and NA/Curaçao also had 
more inadequacies and were more incomplete than data from 
the Netherlands (Table 4). Registered deaths were corrected for 
data inadequacies and incompleteness using PAHO methods, so 
the effects of data quality were minimized as much as possible 
(14). Due to their small populations, the year-to-year fluctuations 
in mortality rates are relatively large in the Dutch Caribbean. 
This made it impossible to run Joinpoint analyses for determin-
ing trend breaks in the mortality series for the Dutch Caribbean.
Another limitation is that cross-country variation in amena-
ble mortality does not automatically imply that differences in 
health care performance are involved (26). Other factors that 
are not related to health care performance, such as disease inci-
dence, may also play a role in generating higher mortality in 
the Dutch Caribbean. Disease incidence is also influenced by 
factors outside of the health care system, such as socioeconomic 
conditions, health behaviors, and environmental factors. Many 
of these factors are less favorable in the Dutch Caribbean. For 
example, income distributions are far more unequal than in the 
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Netherlands (27) and obesity is twice as prevalent in Curaçao 
than in the Netherlands (28). Also, sulfur dioxide emissions 
recorded in Curaçao are among the highest in the world (29). 
Observed differences in amenable mortality in cross-country 
comparisons, however, cannot be solely attributed to differences 
in disease incidence. In two recent studies, amenable mortality 
rates were controlled for incidence of underlying conditions, 
yet substantial cross-country variations remained (30, 31). An 
argument supporting the view that health care performance 
is involved in the mortality differences between the Dutch 
Caribbean and the Netherlands is our finding that amenable 
mortality has generally decreased faster than non-amenable 
mortality during the study period (Table 1). This suggests that 
improvements in health care were at least partly responsible for 
the mortality decline in amenable causes (32). Moreover, the 
identified amenable causes of death with the largest contribu-
tion to life expectancy differences with the Netherlands were 
supported by other information on the health care system, from 
which we conclude that, indeed, the variation in amenable mor-
tality rates reflect differences in the effectiveness of health care 
services between Aruba, Curaçao, and the Netherlands.
Conclusions
Improvements in health care services related to circulatory 
diseases, breast cancer, perinatal deaths, and nephritis/nephro-
sis in the Dutch Caribbean could substantially contribute to 
reducing the gap in life expectancy with the Netherlands. Based 
on our study, we recommend more in-depth studies to identify 
the specific interventions and resources needed to optimize the 
underlying health care areas.
Author contributions. SV conceived the original idea, planned 
the experiments, collected and analyzed the data. All authors 
interpreted the results. SV wrote the paper. HvO and JM criti-
cally revised the paper. All authors reviewed and approved the 
final version.
Conflicts of interest. None declared.
Disclaimer. Authors hold sole responsibility for the views 
expressed in the manuscript, which may not necessarily reflect 
the opinion or policy of the RPSP/PAJPH and/or PAHO.
REFERENCES
 1. United Nations Department of Social and Economic Affairs. World 
Population Prospects: The 2017 Revision [Internet]. 2017 [cited 2019 
Apr 8]. Available from: http://esa.un.org/wpp/index.htm
 2. Verstraeten SPA, van Oers HAM, Mackenbach JP. Differences in life 
expectancy between four Western countries and their Caribbean 
dependencies, 1980-2014. Eur J Public Health. 2019;30(1):85–92.
 3. Snoeijs S, Boerma W. Evaluatie van de structuur van en de zorgver-
lening in de eerstelijnsgezondheidszorg op Curaçao. Utrecht: 
NIVEL; 2012.
 4. Smits JPJM, Droomers M, Westert GP. Sociaal-economische 
status en toegankelijkheid van zorg in Nederland. RIVM rapport 
279601002/2002. Bilthoven: Rijksinstituut voor de Volksgezondheid 
en Milieu (RIVM); 2002.
 5. Alberts JF, Sanderman R, Eimers JM, Van Den Heuvel WJA. Socio-
economic inequity in health care: A study of services utilization in 
Curacao. Soc Sci Med. 1997;45(2):213–20.
 6. Bodok S, Kwidama E, Lourents N, Schroen M, Wijk van N, Kwid-
ama L, et al. Wachten op specialistische zorg op Curaçao: betekent 
PP “Poko Poko”? IV. Willemstad, Curacao: Eilandgebied Curacao; 
2008.
 7. Verstraeten S. Resultaten monitor wachttijden medisch special-
istische zorg. Willemstad, Curacao: Volksgezondheid Instituut 
Curacao; 2017.
 8. Verstraeten S, Griffith M, Pin R. De Nationale Gezondheidsenquête 
2017. Willemstad, Curacao: Volksgezondheid Instituut Curacao; 
2018.
 9. Central Bureau of Statistics. Statline [Internet]. [cited 2016 Nov 29]. 
Available from: http://statline.cbs.nl/Statweb/?LA=nl
10. Verstraeten SPA, Jansen I, Pin R, Brouwer W. De Nationale Gezond-
heidsenquête 2013: methodologie en belangrijkste resultaten. 
Willemstad, Curaçao: Volksgezondheid Instituut Curaçao; 2013.
11. Karssen B, Hurkens K, Jurling B. Resultaten van het onderzoek 
norminkomen apothekers. Willemstad; 2011.
12. World Health Organization. WHO mortality database, April 2018 
update [Internet]. [cited 2018 Oct 1]. Available from: http://www.
who.int/healthinfo/mortality_data/en/
13. Nolte E, McKee M. Does health care save lives? Avoidable mortality 
revisited. London: The Nuffield Trust; 2004.
14. Silvi J. On the estimation of mortality rates for countries of the 
Americas. Epidemiol Bull Pan Am Heal Organ. 2003;24(4):1–5.
15. Ahmad OB, Boschi-Pinto C, Lopez AD, Murray CJL, Lozano R, 
Inoue M. Age Standardization of Rates: A New WHO Standard. 
Geneva; 2001. (GPE Discussion Paper Series).
16. Auger N, Feuillet P, Martel S, Lo E, Barry AD, Harper S. Mortal-
ity inequality in populations with equal life expectancy: Arriaga’s 
decomposition method in SAS, Stata, and Excel. Ann Epidemiol. 
2014;24(8):575–80.
17. Plug I, Hoffmann R, Mackenbach JP, editors. Avoidable mortality in 
the European Union. Volume 1: Final report. Public Health. Rotter-
dam: EU Public Health Program 2007106; 2011.
18. Autier P, Boniol M, Koechlin A, Pizot C, Boniol M. Effectiveness of 
and overdiagnosis from mammography screening in the Nether-
lands: population based study. BMJ. 2017;359(j5224).
19. Agyemang C, Kieft S, Snijder MB, Beune EJ, Van Den Born BJ, Brew-
ster LM, et al. Hypertension control in a large multi-ethnic cohort 
in Amsterdam, The Netherlands: The HELIUS study. Int J Cardiol. 
2015;183:180–9.
20. Snijder MB, Agyemang C, Peters RJ, Stronks K, Ujcic-Voortman JK, 
van Valkengoed IGM. Case Finding and Medical Treatment of Type 
2 Diabetes among Different Ethnic Minority Groups: The HELIUS 
Study. J Diabetes Res. 2017;2017:1–8.
21. Coenen T. Making a difference through health. How PwC is Helping 
to Change Lives. Impact case studies. Oranjestad, Aruba: Pricewa-
terhouseCoopers; 2016.
22. Algemene Rekenkamer Curaçao. Chikungunya, aanpak van de 
bestrijding. Willemstad: Algemene Rekenkamer Curaçao; 2016.
23. Paniz-Mondolfi AE, Tami A, Grillet ME, Márquez M, Hernández- 
Villena J, Escalona-Rodríguez MA, et al. Resurgence of vaccine- 
preventable diseases in Venezuela as a regional public health threat 
in the Americas. Emerg Infect Dis. 2019;25(4):625–32.
24. Grillet ME, Hernández-Villena J V, Llewellyn MS, Paniz-Mondolfi 
AE, Tami A, Vincenti-Gonzalez MF, et al. Venezuela’s humanitar-
ian crisis, resurgence of vector-borne diseases, and implications for 
spillover in the region. Lancet Infect Dis. 2019;3099(18):1–13.
25. Pattinson R, Kerber K, Waiswa P, Day LT, Mussell F, Asiruddin 
S, et al. Perinatal mortality audit: Counting, accountability, and 
overcoming challenges in scaling up in low- and middle-income 
countries. Int J Gynecol Obstet. 2009;107(suppl):S113–21.
26. Mackenbach JP, Hoffmann R, Khoshaba B, Plug I, Rey G, Wester-
ling R, et al. Using “amenable mortality” as indicator of healthcare 
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
N61
Verstraeten et al. • Amenable mortality and life expectancy differences Original research 
Rev Panam Salud Publica 44, 2020 | www.paho.org/journal | https://doi.org/10.26633/RPSP.2020.38 9
effectiveness in international comparisons: results of a validation 
study. J Epidemiol Community Heal. 2013;67(2):139–46.
27. Centraal Bureau voor de Statistiek. Publicatiereeks Census 2011. 
Vierbergen F, editor. Inkomens en inkomensverdelingen. Willems-
tad; 2011.
28. Verstraeten S, Griffith M, Pin R. De nationale gezondheidsenquete 
Curacao 2017. Willemstad: Volksgezondheid Instituut Curaçao; 2018.
29. Pulster EL, Johnson G, Hollander D, McCluskey J, Harbison R. Expo-
sure Assessment of Ambient Sulfur Dioxide Downwind of an Oil 
Refinery in Curaçao. J Environ Prot (Irvine, Calif). 2018;9(3):194–210.
30. Kruk ME, Gage AD, Joseph NT, Danaei G, García-Saisó S, Salomon 
JA. Mortality due to low-quality health systems in the universal 
health coverage era: a systematic analysis of amenable deaths in 137 
countries. Lancet. 2018;392(10160):2203–12.
31. Alkire BC, Peters AW, Shrime MG, Meara JG. The economic con-
sequences of mortality amenable to high-quality health care in 
low- and middle-income countries. Health Aff. 2018;37(6):988–96.
32. Mackenbach J, Bouvier-Colle M, Jougla E. “Avoidable” mortality 
and health services: a review of aggregate data studies. J Epidemiol 
Community Health. 1990;44(2):106–11.
Manuscript received on 26 October 2019. Revised version accepted for publication 
on 24 February 2020.
Contribución de la mortalidad por causas evitables mediante la atención 
de salud a la diferencia de la esperanza de vida entre las islas del Caribe 
holandés de Aruba y Curaçao y los Países Bajos
RESUMEN Objetivo. Determinar las áreas específicas de atención de salud cuya optimización podría mejorar la salud de 
la población en las islas del Caribe holandés de Aruba y Curaçao.
 Métodos. Estudio de observación comparativo en el que se utilizaron datos demográficos y de mortalidad 
de las islas del Caribe holandés y de los Países Bajos. Se calcularon las tendencias de mortalidad y luego 
se analizaron con programas de computación Jointpoint de regresión lineal segmentada, para el período 
1988–2014. La esperanza de vida se calculó utilizando tablas de mortalidad abreviadas con los datos más 
recientes disponibles de todos los territorios (2005–2007). Las diferencias de esperanza de vida entre el 
Caribe holandés y los Países Bajos se desglosaron, usando el método de Arriaga, en contribuciones por 
causas específicas.
 Resultados. En el período 1988–2014, los niveles de mortalidad por causas evitables mediante la atención de 
salud han sido sistemáticamente mayores en Aruba y Curaçao que en los Países Bajos. En el caso de Aruba, 
la brecha en la mortalidad por causas evitables mediante la atención de salud con respecto a los Países Bajos 
no varió significativamente durante el período de estudio; en el caso de Curaçao, la brecha fue mayor. Si la 
mortalidad por causas evitables mediante la atención de salud se redujese a un nivel similar al de los Países 
Bajos, los hombres y las mujeres en Aruba habrían sumado, respectivamente, 1,19 años y 0,72 años a su 
esperanza de vida en el período 2005–2007. En Curaçao, el aumento hubiese sido de 2,06 años y de 2,33 
años. Según el estudio, las causas específicas que más contribuyen a esta diferencia son las enfermedades 
circulatorias, el cáncer de mama, las complicaciones perinatales, y la nefritis/nefrosis (estas últimas dos cau-
sas solamente en Curaçao).
 Conclusiones. Una mejora en los servicios de salud en relación con las enfermedades circulatorias, el cáncer 
de mama, las complicaciones perinatales, y la nefritis/nefrosis en el Caribe holandés podría contribuir sus-
tancialmente a la reducción de la brecha en la esperanza de vida con respecto a los Países Bajos. Por tanto, 
con base en nuestro estudio, recomendamos que se realicen más estudios exhaustivos a fin de determinar 
las intervenciones específicas y los recursos que se necesitan para optimizar las áreas de atención de salud 
involucradas.
Palabras clave Evaluación en salud; indicadores de calidad de la atención de salud; Aruba; Curazao; Países Bajos.
Original research Verstraeten et al. • Amenable mortality and life expectancy differences
10 Rev Panam Salud Publica 44, 2020 | www.paho.org/journal | https://doi.org/10.26633/RPSP.2020.38
Contribuição da mortalidade evitável para as diferenças na expectativa de 
vida entre as ilhas de Aruba e Curaçao, no Caribe holandês, e os Países 
Baixos
RESUMO Objetivo. Identificar áreas específicas da atenção à saúde cuja otimização poderia melhorar a saúde da 
população nas ilhas de Aruba e Curaçao, no Caribe holandês.
 Métodos. Estudo observacional comparativo baseado em dados de mortalidade e populacionais das ilhas 
do Caribe holandês e dos Países Baixos. As tendências de mortalidade foram calculadas e então analisadas 
com o software Joinpoint, no período de 1988 a 2014. As expectativas de vida foram computadas usando 
tábuas de mortalidade resumidas com os dados disponíveis mais recentes de todos os territórios (2005-
2007). As diferenças na expectativa de vida entre o Caribe holandês e os Países Baixos foram desagregadas 
segundo as contribuições específicas por causa usando o método de Arriaga.
 Resultados. No período de 1988 a 2014, os níveis de mortalidade evitável foram consistentemente mais 
elevados em Aruba e Curaçao do que nos Países Baixos. Em Aruba, a diferença na mortalidade evitável em 
comparação com os Países Baixos não mudou significativamente durante o período do estudo, enquanto que 
em Curaçao a diferença aumentou. Se a mortalidade por causas evitáveis fosse reduzida a níveis semelhan-
tes aos dos Países Baixos, os homens e mulheres de Aruba teriam aumentos respectivos de 1,19 e 0,72 anos 
nas suas expectativas de vida durante o período 2005-2007. Em Curaçao, o aumento seria de 2,06 e 2,33 
anos. As maiores contribuições de causas específicas foram as de doenças circulatórias, câncer de mama, 
causas perinatais e nefrite/nefrose (estas duas últimas causas somente em Curaçao).
 Conclusões. Melhorias nos serviços de saúde relacionados com doenças circulatórias, câncer de 
mama, mortes perinatais e nefrite/nefrose no Caribe holandês poderiam contribuir substancialmente para 
reduzir as disparidades na expectativa de vida em comparação com os Países Baixos. Com base neste 
trabalho, recomendamos estudos mais aprofundados para identificar as intervenções e recursos específicos 
necessários para otimizar estas áreas da atenção à saúde.
Palavras-chave Avaliação em saúde; indicadores de qualidade em assistência à saúde; Aruba; Curaçao; Países Baixos.
